On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
We are very excited to launch our new website! Please take a few moments to click around and explore...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...